Baganday, Solidad D.
HRN: 08-49-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
CEFTRIAXONE 1G (VIAL)
06/11/2023
06/17/2023
IV
2g
OD
T/c Sepsis Sec To Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes